Duloxetine use in chronic painful conditions--individual patient data responder analysis.
about
Gabapentin for fibromyalgia pain in adultsTranscutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia in adultsPhysiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and IIMilnacipran for pain in fibromyalgia in adultsAmitriptyline for neuropathic pain in adultsZonisamide for neuropathic pain in adultsMilnacipran for neuropathic pain in adultsAcupuncture for neuropathic pain in adultsNortriptyline for neuropathic pain in adultsMorphine for neuropathic pain in adultsAntipsychotics for fibromyalgiaPregabalin for pain in fibromyalgia in adultsBuprenorphine for neuropathic pain in adultsAntidepressant drugs for neuropathic pain - an overview of Cochrane reviewsHydromorphone for neuropathic pain in adultsBuprenorphine for neuropathic pain in adultsFentanyl for neuropathic pain in adultsTranscutaneous Electrical Nerve Stimulation (TENS) for chronic pain - an overview of Cochrane reviewsCannabinoids for fibromyalgiaAmitriptyline for fibromyalgia in adultsOxycodone for neuropathic pain and fibromyalgia in adultsImipramine for neuropathic pain in adultsTopical lidocaine for neuropathic pain in adultsZonisamide for neuropathic pain in adultsGabapentin for chronic neuropathic pain and fibromyalgia in adultsTopical lidocaine for neuropathic pain in adultsAntiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviewsOxycodone for neuropathic pain in adultsCannabinoids for fibromyalgiaAntipsychotics for fibromyalgia in adultsParacetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adultsHydromorphone for neuropathic pain in adultsCannabinoids for chronic neuropathic painMethadone for neuropathic pain in adultsRelative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysisHigh correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications.Pregabalin for pain in fibromyalgia in adults.Fentanyl for neuropathic pain in adults.Topical capsaicin (high concentration) for chronic neuropathic pain in adults.Gabapentin for chronic neuropathic pain in adults.
P2860
Q24185818-5ABA4474-DBA1-4BEC-8FA9-20EDD772A652Q24185947-A8202054-3E31-4158-AECE-C3BCA2494CFAQ24186109-FCE03D30-5FD1-4124-BEB9-EFC0CC9585D1Q24186461-74864D6B-029E-47A5-BA82-7450A9ACB167Q24186538-2AE67341-A01B-4A9C-AB3C-72965E4F4D48Q24186542-626F1C8D-6784-4574-B076-97F928A018C7Q24186555-C6393DC8-1EFA-4F59-92BA-2084EF4F9A7EQ24186657-C37E1AE5-BF28-4065-86AF-E84A8BCCB1CFQ24186696-0B406238-EBC0-4CC3-AAEF-0EBA2A854B70Q24186741-3BBDAD03-74D9-48CF-A856-235F4968837CQ24186761-4C551FD8-7C64-4F52-A948-9B14A2D7D480Q24186782-1001E09A-73EB-4D65-8CB0-88E5605400B8Q24186924-71F80517-9AF7-408D-99BB-72C82F36C46FQ24186993-A5C448A7-EEC5-41DF-B6EC-80CD529346E6Q24187550-1ADFF78A-F32D-49F5-A81C-1F9BB1125012Q24187555-C4129C65-90A1-4DE4-BA3B-C48863F7CF74Q24187562-639F79DC-CF40-4E36-88CD-20010721DE6CQ24187638-30B2CACC-6A28-48CB-9821-B564C6354C6EQ24188267-A0DD9A1B-BE85-415E-93EE-93AD1D295EFEQ24188299-76C6F2C3-0849-4FE0-9342-BE7B7FD75989Q24193845-D3637D08-7AFE-455D-BBA5-FDF53892F3DCQ24194598-61049286-0A1B-4595-9995-453D02291978Q24194814-6E9F307A-754B-4846-8666-83155506C286Q24194963-930B5754-565F-4EC7-ABBA-83B6BBBF7D3AQ24194998-5B77FED3-310F-4A89-B9CF-9C26FAA6DC53Q24200872-955F5CE5-1057-457B-AD37-B4C6E3E6D863Q24202563-02C4BA3B-0FED-4688-9925-5032E538DFBEQ26470985-47423181-A2CD-4C50-BC9E-ED5BFAA0A33DQ26471052-91054952-7780-43D8-899C-E10A92AB0787Q26471557-D2A0D45F-A9DA-44D6-B5BD-8A53EB4D0299Q26471756-A1E464DB-EE3C-4EB0-8BE7-EC54B0F6BB51Q26471921-EC52D2FC-8109-47B1-B825-496AC12BCA3EQ26472068-0114BFEF-F9E6-4658-9FC2-3196DC00B996Q29994484-A63F808A-9060-42AC-AD89-DC0B1CE3E8A4Q34471991-ACA80A3E-0238-42FC-85C5-C99047C763A6Q34520597-2B62AE32-63D3-46CA-8E23-E5A57ED17C97Q34541472-2861C4AB-7D9D-48CF-87C0-E726B70DC34EQ34542356-17C51106-71A8-4AB1-AA66-3E9441C66F2FQ34549233-64306944-FAB3-4692-ACF4-E4CD309EE726Q34557703-F75B5B71-93C0-4415-B915-85F3015C741B
P2860
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@ast
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@en
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@nl
type
label
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@ast
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@en
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@nl
prefLabel
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@ast
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@en
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@nl
P2093
P2860
P1476
Duloxetine use in chronic painful conditions--individual patient data responder analysis.
@en
P2093
P2860
P356
10.1002/J.1532-2149.2013.00341.X
P577
2013-06-03T00:00:00Z